583 related articles for article (PubMed ID: 24152121)
1. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.
Follett J; Norwood SJ; Hamilton NA; Mohan M; Kovtun O; Tay S; Zhe Y; Wood SA; Mellick GD; Silburn PA; Collins BM; Bugarcic A; Teasdale RD
Traffic; 2014 Feb; 15(2):230-44. PubMed ID: 24152121
[TBL] [Abstract][Full Text] [Related]
2. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant.
Cui Y; Yang Z; Flores-Rodriguez N; Follett J; Ariotti N; Wall AA; Parton RG; Teasdale RD
Traffic; 2021 Apr; 22(4):123-136. PubMed ID: 33347683
[TBL] [Abstract][Full Text] [Related]
3. Retromer's Role in Endosomal Trafficking and Impaired Function in Neurodegenerative Diseases.
Follett J; Bugarcic A; Collins BM; Teasdale RD
Curr Protein Pept Sci; 2017; 18(7):687-701. PubMed ID: 26965691
[TBL] [Abstract][Full Text] [Related]
4. Retromer binding to FAM21 and the WASH complex is perturbed by the Parkinson disease-linked VPS35(D620N) mutation.
McGough IJ; Steinberg F; Jia D; Barbuti PA; McMillan KJ; Heesom KJ; Whone AL; Caldwell MA; Billadeau DD; Rosen MK; Cullen PJ
Curr Biol; 2014 Jul; 24(14):1670-1676. PubMed ID: 24980502
[TBL] [Abstract][Full Text] [Related]
5. Vps26A and Vps26B subunits define distinct retromer complexes.
Bugarcic A; Zhe Y; Kerr MC; Griffin J; Collins BM; Teasdale RD
Traffic; 2011 Dec; 12(12):1759-73. PubMed ID: 21920005
[TBL] [Abstract][Full Text] [Related]
6. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
7. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
[TBL] [Abstract][Full Text] [Related]
8. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N.
Munsie LN; Milnerwood AJ; Seibler P; Beccano-Kelly DA; Tatarnikov I; Khinda J; Volta M; Kadgien C; Cao LP; Tapia L; Klein C; Farrer MJ
Hum Mol Genet; 2015 Mar; 24(6):1691-703. PubMed ID: 25416282
[TBL] [Abstract][Full Text] [Related]
9. Role of the VPS35 D620N mutation in Parkinson's disease.
Mohan M; Mellick GD
Parkinsonism Relat Disord; 2017 Mar; 36():10-18. PubMed ID: 27964832
[TBL] [Abstract][Full Text] [Related]
10. VPS35 and retromer dysfunction in Parkinson's disease.
Rowlands J; Moore DJ
Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220384. PubMed ID: 38368930
[TBL] [Abstract][Full Text] [Related]
11. Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.
Kadgien CA; Kamesh A; Milnerwood AJ
Mol Brain; 2021 Sep; 14(1):143. PubMed ID: 34530877
[TBL] [Abstract][Full Text] [Related]
12. VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.
Chen X; Tsika E; Levine N; Moore DJ
Mol Neurodegener; 2023 Aug; 18(1):51. PubMed ID: 37542299
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease-linked
Chen X; Kordich JK; Williams ET; Levine N; Cole-Strauss A; Marshall L; Labrie V; Ma J; Lipton JW; Moore DJ
Proc Natl Acad Sci U S A; 2019 Mar; 116(12):5765-5774. PubMed ID: 30842285
[TBL] [Abstract][Full Text] [Related]
14. VPS29-VPS35 intermediate of retromer is stable and may be involved in the retromer complex assembly process.
Fuse A; Furuya N; Kakuta S; Inose A; Sato M; Koike M; Saiki S; Hattori N
FEBS Lett; 2015 Jun; 589(13):1430-6. PubMed ID: 25937119
[TBL] [Abstract][Full Text] [Related]
15. Interchangeable but essential functions of SNX1 and SNX2 in the association of retromer with endosomes and the trafficking of mannose 6-phosphate receptors.
Rojas R; Kametaka S; Haft CR; Bonifacino JS
Mol Cell Biol; 2007 Feb; 27(3):1112-24. PubMed ID: 17101778
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of
Sargent D; Moore DJ
Int Rev Mov Disord; 2021; 2():221-244. PubMed ID: 35497708
[TBL] [Abstract][Full Text] [Related]
17. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N.
Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ
Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646
[TBL] [Abstract][Full Text] [Related]
18. Mutation in VPS35 associated with Parkinson's disease impairs WASH complex association and inhibits autophagy.
Zavodszky E; Seaman MN; Moreau K; Jimenez-Sanchez M; Breusegem SY; Harbour ME; Rubinsztein DC
Nat Commun; 2014 May; 5():3828. PubMed ID: 24819384
[TBL] [Abstract][Full Text] [Related]
19. Implication of mouse Vps26b-Vps29-Vps35 retromer complex in sortilin trafficking.
Kim E; Lee Y; Lee HJ; Kim JS; Song BS; Huh JW; Lee SR; Kim SU; Kim SH; Hong Y; Shim I; Chang KT
Biochem Biophys Res Commun; 2010 Dec; 403(2):167-71. PubMed ID: 21040701
[TBL] [Abstract][Full Text] [Related]
20. The Parkinson's disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress.
McCarron KR; Elcocks H; Mortiboys H; Urbé S; Clague MJ
Biochem J; 2024 Feb; 481(4):265-278. PubMed ID: 38299383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
